Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.

Stem cells and development - 10 Aug 2012

Liu Te, Zou Gang, Gao Yongtao, Zhao Xinrong, Wang Hui, Huang Qin, Jiang Lizhen, Guo Lihe, Cheng Weiwei

Abstract excerpt

Although many techniques can be used to generate multitype-induced pluripotent stem (iPS) cells from multitype seed cells, improving the efficiency and shortening the period of cell reprogramming remain troublesome issues. In this study, to generate iPS cells, CD34⁺ cells, isolated from human amniotic fluid cells (HuAFCs) by flow cytometry, were infected with retroviruses carrying only one reprogramming factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkaline Phosphatase
Share to Amniotic Fluid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, CD34

Share to Antigens, Differentiation

Share to Blood Cells

Share to Kruppel-Like Factor 4

Share to Octamer Transcription Factor-3

Share to Schizosaccharomyces pombe Proteins

Source

Identifiers

PMID: 22264161
DOI: 10.1089/scd.2011.0715

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.PMID 22264161Read ↗

Use of Human Amnion Epithelial Cells as a Feeder Layer to Support Undifferentiated Growth of Mouse Embryonic Stem CellsSemantic proximity Read ↗

Induced pluripotent stem cells: opportunities and challengesSemantic proximity Read ↗

Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblastsSemantic proximity Read ↗

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.Semantic proximity Read ↗

Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and DevelopmentSemantic proximity Read ↗

Human Menstrual Blood-Derived Mesenchymal Cells as a Cell Source of Rapid and Efficient Nuclear ReprogrammingSemantic proximity Read ↗

Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)Semantic proximity Read ↗

A novel method to derive amniotic fluid stem cells for therapeutic purposesSemantic proximity Read ↗

Human Endometrial Cells Express Elevated Levels of Pluripotent Factors and Are More Amenable to Reprogramming into Induced Pluripotent Stem CellsSemantic proximity Read ↗

Single OCT4 gene introduced into human bone-marrow derived mesenchymal stromal cells can generate putative iPS cells with the potential to differentiate into CD34+ hematopoietic progenitor cells ex vivoSemantic proximity Read ↗

Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical PerspectivesSemantic proximity Read ↗

Current advances in the generation of human iPS cells: implications in cell-based regenerative medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.